Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma

@inproceedings{Zhou2016PrognosticVO,
  title={Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma},
  author={Mingge Zhou and Yumei Chen and Honghui Huang and Xiang Zhou and Jianping Liu and Gang Huang},
  booktitle={Oncotarget},
  year={2016}
}
PURPOSE We evaluated the prognostic value of total lesion glycolysis (TLG) measured in baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in diffuse large B-cell lymphoma (DLBCL) treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). METHODS A total of 91 patients with newly diagnosed DLBCL underwent 18F-FDG PET/CT scans before R-CHOP therapy. Metabolic tumor volume (MTV) was measured with the marginal… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 30 references

FDG-PET/CT in re-staging of patients with lymphoma

European Journal of Nuclear Medicine and Molecular Imaging • 2003
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…